SRF Temettüler ve Geri Alımlar
Temettü kriter kontrolleri 4/6
SRF kazançlarla iyi bir şekilde karşılanan, 0.4% cari getiriye sahip, temettü ödeyen bir şirkettir.
Anahtar bilgiler
0.4%
Temettü verimi
n/a
Geri Alım Getirisi
| Toplam Hissedar Getirisi | n/a |
| Gelecekteki Temettü Verimi | 0.5% |
| Temettü Büyümesi | 14.7% |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | n/a |
| Ödeme oranı | 14% |
Son temettü ve geri alım güncellemeleri
Recent updates
Anlatı Güncellemesi • Jun 22
503806: Rich P/E And Softer Margins Will Likely Restrain Future Upside
Analysts have kept SRF's price target steady at ₹2,200, with the change in assumptions reflecting a lower discount rate, more moderate revenue growth and profit margin expectations, and a higher future P/E multiple to balance these factors. What's in the News for SRF SRF has scheduled a board meeting on May 5, 2026, to consider and approve the audited financial results for the quarter and year ended March 31, 2026.
Anlatı Güncellemesi • Jun 06
503806: Expanded Capital Outlay Will Support Long Term Performance
Analysts have revised their price target for SRF to ₹3,579 from ₹3,841, citing updated assumptions for revenue growth, profit margins, and the discount rate, while keeping the future P/E expectation broadly similar. What's in the News SRF has scheduled a board meeting on May 5, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026.
Anlatı Güncellemesi • May 22
503806: Expanded Capital Outlay And Dividend Potential Will Support Future Upside
Analysts have trimmed their fair value estimate for SRF from about ₹3,155.83 to ₹2,990.35, reflecting updated assumptions around discount rate, revenue growth, profit margin and future P/E expectations. What's in the News Board meeting scheduled for May 5, 2026, to consider and approve audited financial results for the quarter and year ended March 31, 2026 (company filing).Anlatı Güncellemesi • Apr 30
503806: Future P/E Compression Will Likely Cap Upside Despite Margin Support
The analyst price target for SRF has been adjusted from ₹2,249.74 to ₹2,200.00 as analysts factor in updated assumptions on discount rate, revenue growth, profit margin and future P/E. What's in the News SRF has scheduled a board meeting on May 05, 2026 to consider and approve the audited financial results for the quarter and year ended March 31, 2026 (company filing).Anlatı Güncellemesi • Apr 08
503806: Fair View As Higher Margins Offset Lower Future P/E Multiple
Analysts have raised their fair value estimate for SRF slightly, from ₹2,239.45 to ₹2,249.74. This reflects updated assumptions for revenue growth, profit margins, a lower assumed discount rate, and a reduced future P/E multiple.Anlatı Güncellemesi • Mar 24
503806: Elevated P E And Margins Will Likely Restrain Future Returns
Analysts have modestly increased their fair value estimate for SRF from ₹2,218.36 to ₹2,239.45, citing updated assumptions regarding revenue growth, profit margins, the discount rate, and future P/E, which together support a slightly higher price target. What's in the News SRF's board approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.Anlatı Güncellemesi • Mar 09
503806: Elevated P E And Modest Margins Will Likely Restrain Future Returns
Analysts now set their fair value estimate for SRF at ₹2,218, compared with the previous ₹2,244. This reflects updated assumptions around discount rate, revenue growth, profit margins and future P/E expectations.Anlatı Güncellemesi • Feb 23
503806: Elevated P E And Modest Margin Outlook Will Likely Pressure Returns
Analysts have slightly raised their price target on SRF to ₹2,244, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E. These changes keep their fair value view broadly unchanged in headline terms but reflect a modestly adjusted risk and earnings profile.Anlatı Güncellemesi • Feb 09
503806: Lower Margins And Rich P E Will Likely Pressure Returns
Analysts have raised their price target on SRF to ₹2,244 from ₹2,213, citing updated assumptions on the discount rate, revenue growth, profit margins and a higher future P/E multiple. What's in the News The board has approved the appointment of Mr. Samir Kashyap as Chief Financial Officer, effective January 27, 2026.Anlatı Güncellemesi • Jan 24
503806: New Pharma Plant And CFO Appointment Will Support Future Upside
Analysts have trimmed their price target on SRF to ₹3,155.83 from ₹3,183.00, reflecting slightly more conservative assumptions on revenue growth, profit margin and future P/E, as well as a marginally higher discount rate. What's in the News Board meeting on January 20, 2026 to review unaudited financial results for the quarter and nine months ended December 31, 2025, consider a new pharma intermediate plant project, and discuss a second interim dividend for FY 2025-26 (company filing).Anlatı Güncellemesi • Jan 10
503806: Future Capacity Expansion And CFO Transition Will Support Long Term Prospects
Analysts have kept their fair value estimate for SRF steady at ₹3,841, with only small tweaks to assumptions such as the discount rate, revenue growth, profit margin and future P/E that feed into the updated target. This signals broadly consistent expectations compared with prior research.Anlatı Güncellemesi • Dec 26
503806: Future Specialty Fluoropolymer Capacity Expansion May Support Long Term Profitability
Analysts have modestly raised their price target on SRF to a new level, in line with incremental improvements in projected revenue growth, profit margins, and a slightly lower future valuation multiple, signaling a cautiously stronger outlook for the stock. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025, with SRF initiating the process to identify a successor and ensure a smooth transition (Key Developments).Anlatı Güncellemesi • Dec 12
503806: Lower Discount Rate May Support Stronger Long Term Profitability
Analysts have raised their fair value estimate for SRF by approximately $191 to $3,841 per share, citing a modestly lower discount rate and slightly higher long term profit margin expectations that more than offset a small reduction in projected revenue growth. What's in the News Chief Financial Officer Rahul Jain will step down from his role at the close of business on 12 December 2025.Anlatı Güncellemesi • Nov 27
503806: CFO Transition And New Facility Approval Will Drive Upside Ahead
Analysts have adjusted their price target for SRF slightly upward from $3,182.93 to $3,183.00, citing minor changes in underlying financial assumptions such as discount rate and projected margin. What's in the News Chief Financial Officer Rahul Jain will step down at the close of business on December 12, 2025.Anlatı Güncellemesi • Nov 12
503806: Upcoming CFO Departure And Facility Decision Will Shape Outlook
Analysts have raised their price target for SRF from $3,138.07 to $3,182.93, citing updated forecasts that reflect slight adjustments in growth and profitability assumptions. What's in the News SRF Limited's Chief Financial Officer, Rahul Jain, announced he will step down from his position at the close of business on December 12, 2025.Anlatı Güncellemesi • Oct 29
New Facility And Supply Chain Moves Will Drive Balanced Opportunity Ahead
Analysts have slightly raised their price target for SRF from $3,137.83 to $3,138.07, citing improved profit margin projections as well as a modest increase in anticipated revenue growth. What's in the News SRF Limited will hold a Board Meeting on October 27, 2025, to consider and approve the un-audited financial results for the quarter and half year ended September 30, 2025.Anlatı Güncellemesi • Oct 15
Sustainability And Capacity Upgrades Will Transform Specialty Chemicals
Analysts have increased their price target for SRF from $3,104.79 to $3,137.83, reflecting updated expectations for the company's financial outlook. What's in the News The Chemours Company and SRF Limited have signed strategic agreements to enhance the global supply chain for fluoropolymers and fluoroelastomers (Key Developments).Anlatı Güncellemesi • Sep 05
Sustainability And Capacity Upgrades Will Transform Specialty Chemicals
With no meaningful change in either the discount rate or forward P/E multiple, analysts have maintained SRF's fair value estimate at ₹3105. What's in the News SRF Limited has entered into strategic agreements with The Chemours Company to strengthen Chemours' global supply chain for fluoropolymers and fluoroelastomers, leveraging SRF's manufacturing capabilities.
Yeni Anlatı • Nov 28
Specialty Chemicals Innovations And Global Demand Empower Revenue Growth Journey
SRF's Specialty Chemicals growth and increased production should drive revenue and improve margins due to new product launches and efficiency gains.Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: 503806 şirketinin temettü ödemeleri son 10 yıldır dalgalı seyretti.
Büyüyen Temettü: 503806 şirketinin temettü ödemeleri son 10 yıldır artış göstermektedir.
Piyasaya Karşı Temettü Getirisi
| SRF Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (503806) | 0.4% |
| Pazarın Alt %25'i (IN) | 0.3% |
| Pazarın En İyi %25'i (IN) | 1.5% |
| Sektör Ortalaması (Chemicals) | 0.8% |
| Analist tahmini (503806) (3 yıla kadar) | 0.5% |
Önemli Temettü: 503806 'in temettüsü ( 0.4% ), Indian piyasasındaki temettü ödeyenlerin en alttaki %25'inden ( 0.29% ) daha yüksektir.
Yüksek Temettü: 503806 'in temettüsü ( 0.4% ), Indian piyasasındaki temettü ödeyenlerin en üst %25'ine ( 1.45% ) kıyasla düşüktür.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: Düşük ödeme oranı ( 13.7% ) sayesinde 503806 'un temettü ödemeleri kazançlarla tamamen karşılanmaktadır.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: Oldukça düşük nakit ödeme oranı ( 40.2% ) ile 503806 'un temettü ödemeleri nakit akışları tarafından iyi bir şekilde karşılanmaktadır.
Güçlü temettü ödeyen şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/09/11 03:58 |
| Gün Sonu Hisse Fiyatı | 2026/09/11 00:00 |
| Kazançlar | 2026/06/30 |
| Yıllık Kazançlar | 2026/03/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
SRF Limited 48 Bu analistlerden 27, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| null null | 360 ONE Capital Market Private Limited |
| Nitin Bhasin | Ambit Capital |
| Kumar Saumya Singh | Ambit Capital |